Artivion AORT On-X — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Artivion in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artivion's on-x — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artivion's on-x — total revenues?
- Artivion (AORT) reported on-x — total revenues of $25.95M in Q1 2026.
- How has Artivion's on-x — total revenues changed year-over-year?
- Artivion's on-x — total revenues increased by 20.3% year-over-year, from $21.57M to $25.95M.
- What is the long-term trend for Artivion's on-x — total revenues?
- Over 4 years (2021 to 2025), Artivion's on-x — total revenues has grown at a 15.4% compound annual growth rate (CAGR), from $57.36M to $101.74M.
- What does on-x — total revenues mean?
- This metric represents the total gross revenue generated from the sale of products within the On-X portfolio, which includes specialized mechanical heart valves and related surgical technologies. It serves as a key indicator of market adoption and commercial performance for the company's core cardiac valve replacement offerings. Tracking this revenue stream allows investors to evaluate the growth trajectory and competitive positioning of the company's flagship surgical product line.